Carregant...
Update on Management of Type 2 Diabetes for Cardiologists
The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety...
Guardat en:
| Publicat a: | Methodist Debakey Cardiovasc J |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Methodist Hospital Houston, Texas
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6369620/ https://ncbi.nlm.nih.gov/pubmed/30788013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-14-4-273 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|